The 7th Annual LD Micro Invitational on June 7 & the 2017 Marcum MicroCap Conference on June 16
ANN ARBOR, MI / ACCESSWIRE / May 31, 2017 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRAU), a developer of photo- and
thermo-acoustic medical technologies, has been invited to participate at two upcoming conferences in June 2017.
The 7th Annual LD Micro Invitational is being held on June 6-7, 2017 at the Luxe Sunset Boulevard Hotel in Los Angeles. ENDRA
CEO, Francois Michelon, and CFO, David Wells, are scheduled to present on Wednesday, June 7 at 10:30 a.m. Pacific time with
one-on-one meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with ENDRA
management, please log-in via the link provided in your invitation. You may also email your request to NDRA@mzgroup.us or call
Chris Tyson at (949) 491-8235.
The 2017 Marcum MicroCap Conference is being held on June 15-16, 2017 at the Grand Hyatt Hotel in New York City. ENDRA CEO,
Francois Michelon, and CFO, David Wells, are scheduled to present on Friday, June 16 at 10:30 a.m. Eastern time with one-on-one
meetings held throughout the conference. For additional information or to schedule a one-on-one meeting with ENDRA management,
please log-in via the link provided in your invitation. You may also email your request to NDRA@mzgroup.us or call Chris Tyson at
(949) 491-8235.
About the 7th Annual LD Micro Invitational
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually
(Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday
information on the entire sector, including the first pure microcap index (LDMi), which covers stocks in North American with market
capitalizations between $50M-$300M. It is a non-registered investment advisor. For more details, please click here.
About the 2017 Marcum MicroCap Conference
The Marcum MicroCap Conference is an annual highlight on the investment community calendar. Since its launch in 2012, this event
has become a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to
network with fund managers and high net worth investors who focus on small cap equities. More than 2,000 participants from all
segments of the microcap market participate each year, including senior management, finance and legal executives, venture and lower
middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and
service providers to the microcap marketplace. The agenda will feature presentations by CEOs and CFOs in seven principal industry
sectors, expert panels moderated by industry leaders, and the opportunity for investors to meet with management of presenting
companies on a one-on-one basis. For more information, please click here.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRAU) is a developer of photo- and thermo-acoustic medical technologies bringing
new capabilities to existing ultrasound systems. ENDRA's photo-acoustic solutions currently help global medical researchers screen
and modify disease models with high image quality and volume scanning speed. ENDRA has a global installed base of leading
institutions using the Nexus-128 system, the only commercially available 3D imaging system for imaging anatomy, physiology and
labeled molecular targets. ENDRA's thermo-acoustic technology is being developed to enable clinicians to use their existing
ultrasound equipment to visualize tissue function, composition, and monitor a variety of therapeutic interventions - at the point
of care. This directly aligns with current healthcare trends to improve patient access, clinical effectiveness, safety and cost.
For more information, please visit www.endrainc.com. Social media coverage on ENDRA's May 9, 2017 IPO can be found here on Twitter,
here on Facebook and here on LinkedIn.
Company Contact: David Wells Chief Financial Officer (734) 997-0464 investors@endrainc.com www.endrainc.com Media & Investor
Relations Contact: MZ North America Chris Tyson Managing Director (949) 491-8235 NDRA@mzgroup.us www.mzgroup.us
SOURCE: ENDRA Life Sciences Inc.
